Bioventus (BVS) Long-Term Investments (2020 - 2026)

Bioventus (BVS) has reported Long-Term Investments for 7 consecutive years, with $3.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Investments rose 107.88% year-over-year to $3.5 million; the trailing twelve-month figure through Jun 2026 stood at $3.5 million (up 107.88% YoY), and the FY2025 full-year result was $2.3 million, up 21.19% from the prior year.
• Long-Term Investments grew to $3.5 million in Q2 2026 per BVS's latest filing, from $2.1 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $78.5 million in Q3 2022 and bottomed at $1.7 million in Q2 2025.
• Historically, Long-Term Investments has averaged $9.2 million across 5 years, with a median of $2.6 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Long-Term Investments surged 302.84% in 2022, then sank 91.67% in 2023.
• Over 5 years, Long-Term Investments stood at $2.6 million in 2022, then gained by 19.84% to $3.1 million in 2023, then slumped by 39.76% to $1.9 million in 2024, then increased by 21.19% to $2.3 million in 2025, then soared by 52.94% to $3.5 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $3.5 million, $2.1 million, and $2.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.